BioSpace News Archive

AB Science SA (Euronext - FR0010557264 - AB) today announced that the European Patent Office has issued a Notice of Allowance for a patent relating to methods of treating (mCRPC) with its lead compound masitinib, based on findings from study AB12003.

Secretome Therapeutics, a biotechnology company developing first-in-class therapeutics derived from neonatal mesenchymal stem cells (nMSC) for the treatment of underserved diseases, today announced the appointment of Deepa Prasad as Chief Financial Officer.

ERYTECH (Nasdaq & Euronext: ERYP) and PHERECYDES announce merger and name change to PHAXIAM Therapeutics, a clinical-stage biopharmaceutical company developing innovative extended bacteriophage therapies to target antimicrobial resistance (AMR).

Roivant Sciences (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, June 28, 2023, to report its financial results for the fourth quarter and fiscal year ended March 31, 2023, and provide business update.

Politan Capital Management, a 9% shareholder of Masimo Corporation, commented on the outcome of the Company’s Annual Meeting of Stockholders.

Acadia Pharmaceuticals Inc. announced that on June 13, 2023, the Compensation Committee of Acadia’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 153,615 shares of common stock and 56,399 restricted stock units to 28 new employees under Acadia’s 2023 Inducement Plan.

Today, findings from two phase 2 clinical trials showcase new data for an investigational, once-weekly injectable glucose-dependent insulinotropic polypeptide (GIP)/ glucagon-like peptide 1 (GLP-1)/glucagon (GCG) receptor agonist, retatrutide.

Option Care Health, Inc. announced that it has terminated its previously announced agreement to combine with Amedisys, Inc.

Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia’s investigational dual endothelin receptor antagonist evaluating the treatment of patients with resistant hypertension, were presented as an oral presentation.

On June 23-24, SAPA-GP held the 2023 @Philly Cell and Gene Therapy Annual Conference at the Sheraton Valley Forge Hotel in the suburb of Philadelphia.